Form 4: Bayview Legacy Sells 50,000 Arteris Shares

Bayview Legacy, LLC, a 10% owner of Arteris, Inc., reported the sale of 50,000 shares of common stock at a weighted average price of $14.7366.

Summary

• Bayview Legacy, LLC, a 10% owner of Arteris, Inc. (AIP), disposed of 50,000 shares of common stock.
• The transaction occurred on November 10, 2025, at a weighted average sale price of $14.7366 per share.
• The shares were sold in multiple transactions with prices ranging from $14.34 to $14.95.
• This sale was executed pursuant to a Rule 10b5-1 trading plan adopted by Bayview Legacy, LLC on March 5, 2025.
• Following this transaction, Bayview Legacy, LLC beneficially owns 9,639,071 shares of Arteris, Inc. common stock.
• K. Charles Janac, manager of Bayview Legacy, LLC, is deemed to have voting and dispositive power over these shares and filed a separate Form 4 for the same transaction.

Sentiment

Score: 5

Explanation: A Form 4 filing reports an insider transaction, which is a factual disclosure. The sale was pre-planned under a 10b5-1 plan, indicating it is not necessarily a reaction to new information, thus a neutral sentiment.

Industry Context

This filing is a standard disclosure of an insider transaction and does not provide broader industry context or trends. It reflects a specific ownership change within Arteris, Inc.

Related Party Transactions

• K. Charles Janac, manager of Bayview Legacy, LLC, is deemed to have voting and dispositive power over the shares beneficially owned by Bayview Legacy, LLC and filed a separate Form 4 for the same transaction.

Stakeholder Impact

• Shareholders may note the reduction in holdings by a significant 10% owner, though the pre-planned nature of the sale under a 10b5-1 plan suggests it is not based on new, undisclosed material information.

Key Dates

Recommendation

The filing reports a pre-planned sale of shares by a 10% owner under a 10b5-1 plan. While an insider sale, the pre-scheduled nature suggests it is not driven by new, adverse material information. Without additional financial or strategic updates, this transaction alone does not provide sufficient grounds for a change in investment recommendation, thus a 'hold' stance is appropriate.

Keywords

Arteris Inc, AIP, Bayview Legacy LLC, K. Charles Janac, Form 4, Insider Sale, Stock Transaction, 10b5-1 Plan, Common Stock